Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medifast Inc (MED)

Medifast Inc (MED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medifast Inc 100 International Drive Baltimore MD 21202 USA

P: 410-581-8042

Description:

Medifast is a leading manufacturer and distributor of clinically proven healthy living products and programs. It is the brand recommended by more than 20,000 Doctors. Medifast produces, distributes, and sells weight loss and other health-related products through websites, multi-level marketing, telemarketing, franchised weight loss clinics, and medical professionals. The company launched OPTAVIA, an exclusive brand and product line sold through its community of independent Coaches who offer support and guidance to their Clients. In partnership with OPTAVIA Coaches , franchise partners, resellers and its Scientific Advisory Board, Medifast offers comprehensive wellness products and programs that focus on creating sustainable change by helping people learn to incorporate healthy habits into their lives.

Key Statistics

Overview:

Market Capitalization, $K 1,925,251
Shares Outstanding, K 11,781
Annual Sales, $ 713,670 K
Annual Net Income, $ 77,920 K
Last Quarter Sales, $ 178,460 K
Last Quarter Net Income, $ 18,480 K
60-Month Beta 1.33
% of Insider Shareholders 4.00%
Float, K 11,310
% Float 96.00%

Growth:

1-Year Return 57.21%
3-Year Return 221.25%
5-Year Return 466.25%
5-Year Revenue Growth 150.16%
5-Year Earnings Growth 215.34%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.66 on 02/26/20
Next Earnings Date 08/05/20
Earnings Per Share ttm 6.19
EPS Growth vs. Prev Qtr 1.55%
EPS Growth vs. Prev Year 12.00%
Annual Dividend Rate, $ 4.52
Annual Dividend Yield 2.77%
Most Recent Dividend 1.130 on 06/29/20
Next Ex-Dividends Date 06/29/20
Dividend Payable Date 08/06/20
Dividend Payout Ratio 59.46

MED Ratios

Ratio
Price/Earnings ttm 25.69
Price/Earnings forward 48.91
Price/Earnings to Growth N/A
Return-on-Equity % 68.55%
Return-on-Assets % 36.74%
Profit Margin % 10.92
Net Margin % 7.59
Debt/Equity 0.00
Price/Sales 2.71
Price/Cash Flow 24.71
Price/Book 16.59
Book Value/Share 9.40
Interest Coverage 0.00

MED Dividends

Date Value
06/29/20 $1.1300
03/30/20 $1.1300
12/26/19 $1.1300
09/26/19 $0.7500
06/27/19 $0.7500
03/28/19 $0.7500
12/20/18 $0.7500
09/20/18 $0.4800
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar